Results

Total Results: 461 records

Showing results for "depression screening".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_executive.pdf
    May 01, 2013 - However, the prevalence of depressive symptoms not meeting diagnostic criteria for depression may be … and treatment, despite showing improvement in depressive symptoms. … , and although they suggest an improvement in depressive symptoms with screening, there are limited … for screening (major depression alone vs. major and minor depression), and, if screening is to be performed … symptoms are substantially improved when screening, diagnosis, and treatment are provided by the same
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-200-comments-post-acs.pdf
    November 14, 2017 - Some published studies used elevated depressive symptoms rather than depression diagnosis as eligibility … We agree that subthreshold depressive symptoms can be important. … who had clinically important depressive symptoms using a validated depression scale. … Peer Reviewer #2 Results The description of the efficacy of depression treatments on depressive symptomssymptoms in first week after ACS versus targeting patients with persistently elevated depressive symptoms
  3. effectivehealthcare.ahrq.gov/products/depression-postpartum-screening/research
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury-surveillance-160902.pdf
    January 30, 2014 - " Depression"Scale"scores"(HADS)"(treatment"M=10.63"[2.67]h"waitlist"M=9.56"[3.09])"suggest" that"participants"experienced"mildKtoKmoderate"depressive"symptoms … $symptoms$(CES"D$M=16$[mild$ depression]S$n=67)$found$a$significant$ reduction$in$depressive$symptoms … $and$anxiety$and$reducing$depressive$symptoms. … $symptoms$ (CES"D$M=16$[mild$ depression]S$n=67)$found$a$ significant$reduction$in$ depressive$symptoms … $Brain$morphometry$changes$and$ depressive$symptoms$after$traumatic$brain$injury.$Psychiatry!
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
    May 01, 2013 - Clarify that EPDS, PDSS and BDI-II are screening instruments that would detect PP depressive symptoms … Cheryl Beck's research shows that half of women with antepartum depressive symptoms go on to have PPD … symptoms (APDS). … depressive symptoms and improvement in overall mental health [low level evidence, p 42] -All screening … associated with failure for depressive symptoms to improve.
  6. effectivehealthcare.ahrq.gov/sites/default/files/related_files/evidence-summary-cer-200-post-acs-depression.pdf
    November 01, 2017 - Diagnostic Accuracy of Screening and Treatment of Post–Acute Coronary Syndrome Depression: A Systematic … Post-ACS Screening Strategies A number of screening tools for depression have been developed. … • Available depression-screening tools may miss 3 percent of people with depression, but less than … Hispanic, 33%; African American, 26% Mean age range: 57.6 to 61.1 years Depressive disorders: Persistent depressivesymptoms, major or minor depressive disorder, dysthymia, or ICD-10 depressive disorder (diagnoses 29
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0367_11-08-2010.pdf
    January 01, 2010 - and treatment for depression Comparator(s): Different approaches to screening and treatment, including … approaches, safety and efficacy of treatment, improvements in depressive symptoms, parenting skills … for depression? … Efficacy and Safety of Screening and Treatment of Postpartum Depression Nomination Summary Document … review will be broadened to screening and treatment of perinatal depression.
  8. effectivehealthcare.ahrq.gov/products/depression-postpartum-screening/research-protocol
  9. effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-pregnancy-postpartum_research-protocol.pdf
    March 29, 2013 - symptoms and added treatment during the time of conception. … Characteristics of diagnosis—whether depression was detected during screening or not, time of diagnosis … • Subthreshold depressive symptoms which have become the subject of clinical attention. … Speed and duration of response/remission o Relapse o Recurrence o Change in core depressive symptoms … Prevalence of mood symptoms and depressions during pregnancy: implications for clinical practice and
  10. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … For many patients, single ketamine doses often reduce depressive symptoms within 2 hours, with improvements … Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on … Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major
  11. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … Of soldiers referred via the Post Deployment Health Assessment screening process, only 54% follow through … Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on … Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT- resistant major
  12. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … contraindications for anticholinergic medication could limit adoption and cautioned that appropriate patient screening … Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on … Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT- resistant major
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-postpartum-screening_research-protocol.pdf
    May 01, 2013 - Perinatal Depression: Prevalence, Screening Accuracy, and Screening Outcomes. … Perinatal depression: prevalence, screening accuracy, and screening outcomes. … Maternal depressive symptoms at 2 to 4 months post partum and early parenting practices. … Obstetric, somatic, and demographic risk factors for postpartum depressive symptoms. … /diagnosis[mesh] OR mass screening[mesh] OR questionnaires[mesh] OR Interviews as Topic[Mesh] OR Psychometrics
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury_executive.pdf
    April 01, 2011 - Clinicians, caregivers, and patients lack formal evidence to guide the timing of depression screening … KQ2: Screening for Depression After TBI Content of literature. … The second study128 investigated the effect of citalopram on depressive symptoms after TBI, using an … Risk factors for depressive symptoms after mild-to-moderate traumatic brain injury. … Attention and depressive symptoms in chronic phase after traumatic brain injury.
  15. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
    October 01, 2014 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screeningsymptoms in both bipolar disorder and MDD, although its exact mechanism of action is still unknown … Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on … Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT- resistant major
  16. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_june_2012.pdf
    January 01, 2012 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … Of soldiers referred via the Post Deployment Health Assessment screening process, only 54% follow through … Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on … Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT- resistant major
  17. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … , potentially restoring normal emotional processing and easing depressive symptoms.69 Clinical data … Course of improvement in depressive symptoms to a single intravenous infusion of ketamine vs add-on … Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT- resistant major
  18. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression_hi_impact.pdf
    October 01, 2014 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … believe that dysfunction in glutamate neurotransmission could play a major role in the etiology of depressivesymptoms, although its exact mechanism of action is still unknown. 24 Research suggests that N-methyl-D-aspartate … , investigators concluded, “Within 40 minutes, depressive symptoms significantly improved in subjects
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/acs-depression-research-protocol-amended.pdf
    February 15, 2017 - outcomes • Response or remission of depressive symptoms using validated continuous or categorical … outcomes § Response or remission of depressive symptoms using validated continuous or categorical … For depressive symptoms and QOL, it is likely that studies will use different instruments to measure … depressive symptoms using a validated depression scale, and are within 3 months of an acute ACS event … /diagnosis"[Mesh] OR mass screening[mesh] OR questionnaires[mesh] OR Interviews as Topic[Mesh] OR Psychometrics
  20. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … and the severity of certain depressive symptoms. … symptoms observed in BPD and MDD.4 Preclinical studies indicate that ketamine’s antidepressant properties … Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: